ZymoGenetics was acquired by Bristol-Myers Squibb for $885 million
On Oct. 12, 2010, Bristol-Myers Squibb Company announced it had completed its acquisition of ZymoGenetics. Bristol-Myers Squibb initiated…
On Oct. 12, 2010, Bristol-Myers Squibb Company announced it had completed its acquisition of ZymoGenetics. Bristol-Myers Squibb initiated…
British Columbia BioEvolution illustrates life science companies and non-profit research organization in the Province of British Columbia by…
On Jan. 17, 2008, ZymoGenetics received U.S. Food and Drug Administration (FDA) authorization to manufacture the product Thrombin…
On Apr. 14, 2003, researchers at Canada’s Michael Smith Genome Science Centre in Vancouver announced they had sequenced…
On Jan. 10, 2002, ZymoGenetics, a former Novo Nordisk subsidiary, announced its IPO at $12.00 per share with…
On Apr. 24, 2001, Genome Canada announced $136 million in funding to support 22 large-scale research projects and…
On Jul. 31, 2000, Genome British Columbia was founded as one of six Genome Canada centres across the…
In 1999, the Vancouver Prostate Centre received a $20 million donation by Vancouver businessman Jim Pattison, the largest…
In 1997, the Univerity of British Columbia (UBC) approved an agreement with the BC Centre for Disease Control…
In 1993, Dr. Michael Smith from the University of British Columbia in Vancouver was awarded one half the…
In 1991, Life Sciences BC, a non-profit industry association (LBC) formerly known as BC Biotech, was founded. The…
In 1986, BC Transplant (BCT) was established. BCT directs, delivers or contracts for all organ transplant services across…
On Jun. 22, 1981, ZymoGenetics was founded by University of Washington professors Earl Davie and Benjamin Hall, and…
On Nov. 5, 1938, the British Columbia Cancer Institute, BC Cancer’s first cancer treatment centre officially opened in…
In 1908, the University of British Columbia (UBC) was founded by The University Act. In 1910 a site…